Etodolac 200 mg

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac capsules are indicated: • For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis • For the management of acute pain

Apotex Corp.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] nausea` `[4] arthralgia` `[5] fatigue` `[6] headache` `[7] dyspnoea` `[8] diarrhoea` `[9] dizziness` `[10] rash`

4 years ago

CAPSULE GREY APO 039

4 years ago

APO 039 CAPSULE GREY

HOW SUPPLIED

ETODOLAC capsules, USP are available as: 200 mg capsules (Hard gelatin capsules with a white opaque body and a light gray cap. “APO 039” is imprinted on each capsules in black ink) - in bottles of 100, NDC 60505-0039-1 300 mg capsules (Hard gelatin capsules with a white opaque body and a light gray cap. “APO 040” is imprinted on each capsules in black ink) - in bottles of 100, NDC 60505-0040-1 Store at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in tight, light-resistant container [see USP]. Dispense with Medication Guide available at www1.apotex.com/products/us APOTEX INC.

ETODOLAC capsuleS, USP 200 mg and 300 mg Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 Revised: December 2021 Rev. 9

More pills like CAPSULE APO 039

Related Pills

etodolac 300 mg

apotex corp.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site